Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,002,688
  • Shares Outstanding, K 70,375
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 341 M
  • EBITDA $ 422 M
  • 60-Month Beta 1.35
  • Price/Sales 9.63
  • Price/Cash Flow 63.89
  • Price/Book 14.99

Options Overview Details

View History
  • Implied Volatility 47.23% ( +0.35%)
  • Historical Volatility 21.57%
  • IV Percentile 71%
  • IV Rank 47.28%
  • IV High 69.71% on 08/05/24
  • IV Low 27.06% on 05/13/25
  • Put/Call Vol Ratio 0.89
  • Today's Volume 34
  • Volume Avg (30-Day) 278
  • Put/Call OI Ratio 2.22
  • Today's Open Interest 11,601
  • Open Int (30-Day) 10,894

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.93
  • Number of Estimates 11
  • High Estimate 1.13
  • Low Estimate 0.78
  • Prior Year 0.55
  • Growth Rate Est. (year over year) +69.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
282.80 +0.51%
on 07/17/25
316.00 -10.05%
on 06/30/25
-17.56 (-5.82%)
since 06/18/25
3-Month
237.49 +19.68%
on 04/21/25
329.33 -13.69%
on 05/21/25
+37.43 (+15.17%)
since 04/17/25
52-Week
173.00 +64.29%
on 08/09/24
329.33 -13.69%
on 05/21/25
+89.27 (+45.79%)
since 07/18/24

Most Recent Stories

More News
Stocks Settled Mixed as Higher Bond Yields Weigh on Sentiment

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.11%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.91%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.89%. September E-mini...

AVGO : 283.34 (-1.09%)
TTD : 80.21 (-1.51%)
LVS : 48.67 (-0.53%)
WYNN : 106.77 (-2.44%)
$IUXX : 23,065.47 (-0.05%)
ASML : 734.58 (-1.39%)
ZNU25 : 110-250s (+0.24%)
R : 169.90 (-1.22%)
TSLA : 329.65 (+3.21%)
ESU25 : 6,334.75s (-0.09%)
SG : 14.31 (+5.30%)
AMD : 156.99 (-2.13%)
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential

BEAM : 20.75 (+1.47%)
INSP : 126.83 (-0.89%)
LFMD : 10.55 (-4.95%)
KRYS : 147.49 (-1.77%)
OPCH : 29.48 (-1.54%)
VEEV : 282.29 (+2.11%)
TMDX : 109.88 (-2.35%)
PODD : 284.23 (+0.28%)
CERT : 10.10 (-4.17%)
TEM : 60.98 (+0.54%)
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

PODD : 284.23 (+0.28%)
IHI : 60.06 (+0.15%)
DXCM : 83.89 (-0.25%)
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END

AVAI : 0.6100 (+1.67%)
TNDM : 14.77 (-3.84%)
NVO : 64.31 (-1.50%)
PODD : 284.23 (+0.28%)
MDT : 89.61 (+0.09%)
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

AVAI : 0.6100 (+1.67%)
TNDM : 14.77 (-3.84%)
NVO : 64.31 (-1.50%)
PODD : 284.23 (+0.28%)
MDT : 89.61 (+0.09%)
DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

XLV : 131.84 (-0.66%)
PODD : 284.23 (+0.28%)
DXCM : 83.89 (-0.25%)
3 Medical Technology Stocks Outperforming in 2025

Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.

GRAL : 35.19 (-2.03%)
TMDX : 109.88 (-2.35%)
PODD : 284.23 (+0.28%)
Do Wall Street Analysts Like Insulet Stock?

Insulet has significantly outpaced the broader market over the past year, and analysts remain bullish on the stock’s prospects.

C : 93.45 (+0.39%)
$SPX : 6,296.79 (-0.01%)
PODD : 284.23 (+0.28%)
IHI : 60.06 (+0.15%)
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

Insulet's earnings and upgraded guidance recently propelled its stock to S&P 500 leadership, showcasing strong execution in the diabetes care market.

PODD : 284.23 (+0.28%)
Dow leaps 1,100 points and S&P 500 rallies 3.3% following a 90-day truce in the US-China trade war

U.S. stocks rallied after China and the United States announced a 90-day truce in their trade war

NVDA : 172.41 (-0.34%)
NRG : 151.75 (+2.97%)
AVGO : 283.34 (-1.09%)
BMO.TO : 156.85 (-0.22%)
$SPX : 6,296.79 (-0.01%)
JNJ : 163.70 (+0.44%)
EXPE : 184.93 (+1.57%)
ABNB : 139.34 (+0.03%)
$IUXX : 23,065.47 (-0.05%)
PFE : 24.47 (-0.45%)
DAL : 56.29 (-0.09%)
SG : 14.31 (+5.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 289.02
2nd Resistance Point 287.75
1st Resistance Point 285.99
Last Price 284.23
1st Support Level 282.96
2nd Support Level 281.69
3rd Support Level 279.93

See More

52-Week High 329.33
Last Price 284.23
Fibonacci 61.8% 269.61
Fibonacci 50% 251.16
Fibonacci 38.2% 232.72
52-Week Low 173.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar